Philippe Sauvage, Chief Financial Officer at Nuvation Bio Inc. (NUVB), sold 47,668 shares at $6.01 ($286K) on 2026-06-23, disclosed to the SEC on 2026-06-24.
Scheduled sale ($286k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.